Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jana Portnow
247. Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Assessment of Pain Caused by Invasive Procedures in Cancer Patients
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Related publications
Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma
Annals of Lymphoma
768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Pre-Clinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma
Haematologica
Hematology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Chimeric Antigen Receptor Transduced T Cells - Tuning Up for the Next Generation
International Journal of Cancer
Cancer Research
Oncology
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons
Neurosurgical Focus
Medicine
Surgery
Neurology
Clinical Chimeric Antigen Receptor‐T Cell Therapy: A New and Promising Treatment Modality for Glioblastoma
Clinical and Translational Immunology
Allergy
Immunology
Nursing
Development of GPC3-specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery